Cytokinetics Newsroom

Truist Financial Maintains Cytokinetics(CYTK.US) With Buy Rating

Futu NewsDec 23 20:31

Truist Financial Sticks to Their Buy Rating for Cytokinetics (CYTK)

TipRanksDec 23 20:17

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Futu NewsDec 21 03:31

Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow JonesDec 20 23:29

RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Raises Target Price to $82

Futu NewsDec 19 18:34

Cytokinetics Is Maintained at Outperform by RBC Capital

Dow JonesDec 18 23:54

Cytokinetics Analyst Ratings

BenzingaDec 18 23:44

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $62 to $120

Futu NewsDec 3 21:01

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), PTC Therapeutics (PTCT) and Vir Biotechnology (VIR)

TipRanksDec 3 18:52

Cytokinetics Price Target Maintained With a $72.00/Share by Needham

Dow JonesDec 2 23:23

Cytokinetics Analyst Ratings

BenzingaDec 2 23:13

Promising Prospects for Cytokinetics: Aficamten's Strong Phase 3 Results and Strategic Bayer Collaboration Drive Buy Rating

TipRanksDec 2 22:26

RBC Capital Sticks to Its Buy Rating for Cytokinetics (CYTK)

TipRanksNov 28 09:49

Cytokinetics Is Maintained at Outperform by Mizuho

Dow JonesNov 21 21:20

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $70 to $120

Futu NewsNov 20 21:01

Cytokinetics' Hold Rating Amid Bayer Partnership and Acquisition Uncertainty

TipRanksNov 20 19:18

Cytokinetics Gains 'Buy' Rating Due to Strategic Collaborations and Potential FDA Approval

TipRanksNov 20 05:07

Cytokinetics Analyst Ratings

BenzingaNov 20 01:46

H.C. Wainwright Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $120

Futu NewsNov 19 16:42

Positive Clinical Outcomes Drive Buy Rating for Cytokinetics's Cardiac Myosin Modulators

TipRanksNov 18 19:21